Search details
1.
Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma.
Cell
; 175(1): 101-116.e25, 2018 09 20.
Article
in English
| MEDLINE | ID: mdl-30220459
2.
Amplifying the Noise: Oncometabolites Mask an Epigenetic Signal of DNA Damage.
Mol Cell
; 79(3): 368-370, 2020 08 06.
Article
in English
| MEDLINE | ID: mdl-32763225
3.
DNA damage in IDH-mutant gliomas: mechanisms and clinical implications.
J Neurooncol
; 162(3): 515-523, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36352183
4.
Peptidic degron for IMiD-induced degradation of heterologous proteins.
Proc Natl Acad Sci U S A
; 116(7): 2539-2544, 2019 02 12.
Article
in English
| MEDLINE | ID: mdl-30683719
5.
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase.
Proc Natl Acad Sci U S A
; 115(16): E3741-E3748, 2018 04 17.
Article
in English
| MEDLINE | ID: mdl-29610306
6.
Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.
Blood
; 119(20): 4686-97, 2012 May 17.
Article
in English
| MEDLINE | ID: mdl-22452979
7.
Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy.
bioRxiv
; 2024 Jan 23.
Article
in English
| MEDLINE | ID: mdl-38328251
8.
Emerging roles of nucleotide metabolism in cancer.
Trends Cancer
; 9(8): 624-635, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37173188
9.
Preclinical modeling of lower-grade gliomas.
Front Oncol
; 13: 1139383, 2023.
Article
in English
| MEDLINE | ID: mdl-37051530
10.
Protocol to establish a genetically engineered mouse model of IDH1-mutant astrocytoma.
STAR Protoc
; 4(2): 102281, 2023 May 06.
Article
in English
| MEDLINE | ID: mdl-37149859
11.
Human plasma-like medium facilitates metabolic tracing and enables upregulation of immune signaling pathways in glioblastoma explants.
bioRxiv
; 2023 May 31.
Article
in English
| MEDLINE | ID: mdl-37398280
12.
Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma.
Neurooncol Adv
; 5(1): vdad085, 2023.
Article
in English
| MEDLINE | ID: mdl-37554222
13.
Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trials.
Neurooncol Adv
; 5(1): vdad053, 2023.
Article
in English
| MEDLINE | ID: mdl-37287696
14.
(R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers.
Cancer Discov
; 13(6): 1478-1497, 2023 06 02.
Article
in English
| MEDLINE | ID: mdl-36847506
15.
Selective and brain-penetrant lanosterol synthase inhibitors target glioma stem-like cells by inducing 24(S),25-epoxycholesterol production.
Cell Chem Biol
; 30(2): 214-229.e18, 2023 02 16.
Article
in English
| MEDLINE | ID: mdl-36758549
16.
Semi-Automated Computational Assessment of Cancer Organoid Viability Using Rapid Live-Cell Microscopy.
Cancer Inform
; 21: 11769351221100754, 2022.
Article
in English
| MEDLINE | ID: mdl-35652106
17.
Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas.
Acta Neuropathol Commun
; 10(1): 32, 2022 03 09.
Article
in English
| MEDLINE | ID: mdl-35264242
18.
Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers.
Cancer Res
; 82(4): 665-680, 2022 02 15.
Article
in English
| MEDLINE | ID: mdl-34911787
19.
Chromosomal instability in adult-type diffuse gliomas.
Acta Neuropathol Commun
; 10(1): 115, 2022 08 17.
Article
in English
| MEDLINE | ID: mdl-35978439
20.
Establishment of patient-derived organoid models of lower-grade glioma.
Neuro Oncol
; 24(4): 612-623, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-34850183